Nuvation Bio's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Nuvation Bio is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -13.79M	$ -19.65M	$ -20.64M	$ -26.70M	$ -21.78M
EBITDA	$ -16.99M	$ -23.02M	$ -23.80M	$ -28.80M	$ -21.98M
Net Income Common Stockholders	$ -16.02M	$ -18.55M	$ -20.64M	$ -19.14M	$ -18.25M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 611.21M	$ 619.34M	$ 630.90M	$ 646.61M	$ 661.01M
Total Assets	$ 621.48M	$ 630.87M	$ 641.41M	$ 657.06M	$ 672.14M
Total Debt	$ 4.01M	$ 4.46M	$ 3.68M	$ 3.97M	$ 4.26M
Net Debt	$ -607.21M	$ -614.88M	$ -627.22M	$ -642.64M	$ -656.75M
Total Liabilities	$ 16.36M	$ 19.28M	$ 16.78M	$ 15.99M	$ 672.14M
Stockholders Equity	$ 605.12M	$ 611.59M	$ 624.60M	$ 641.07M	$ 655.08M
Cash Flow	-
Free Cash Flow	$ -15.00M	$ -16.21M	$ -17.54M	$ -19.31M	$ -16.23M
Operating Cash Flow	$ -15.00M	$ -16.18M	$ -17.52M	$ -19.30M	$ -16.17M
Investing Cash Flow	$ 33.16M	$ -9.59M	$ 37.35M	$ -52.00M	$ -21.83M
Financing Cash Flow	$ 120.00K	$ 77.00K	$ 133.00K	$ 298.00K	$ 407.00K

Currency in USD

Nuvation Bio Earnings and Revenue History

Income Statement >

Nuvation Bio Debt to Assets

Balance Sheet >

Nuvation Bio Cash Flow

Cash Flow >

Nuvation Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing